Pricing Log in Create free account

Addex Therapeutics Ltd. Sponsored ADR (ADXN) vs Revelation Biosciences, Inc. (REVB)

Addex Therapeutics Ltd. Sponsored ADR and Revelation Biosciences, Inc. are both Biotechnology companies. Addex Therapeutics Ltd. Sponsored ADR and Revelation Biosciences, Inc. are of similar size ($3.2M and $3.0M). Across the 10 metrics below, Addex Therapeutics Ltd. Sponsored ADR leads on 6 and Revelation Biosciences, Inc. on 4.

Valuation

Metric ADXN REVB Biotechnology median
P/E n/m n/m 8.50
P/S 27.97 n/m 9.71
P/B 1.17 0.18 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.86 0.64
EV/Sales 18.34 n/m 9.21
Earnings yield (318.34%) (2,564.58%) (33.15%)
Free cash flow yield (104.65%) (513.59%) (25.50%)

Profitability

Metric ADXN REVB Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (154.91%) (276.43%) (56.36%)
Return on assets (117.46%) (214.63%) (48.04%)
Return on invested capital (141.24%) 0.00% 0.00%

Growth

Metric ADXN REVB Biotechnology median
Revenue growth (TTM) (89.37%) — 6.02%
EPS growth (last fiscal year) (191.09%) 97.72% 30.26%
Revenue growth, 5-year CAGR (60.68%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ADXN REVB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.76 6.21 4.72
Net debt to EBITDA 0.58 1.18 0.96

Dividend

Metric ADXN REVB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ADXN REVB Biotechnology median
Market cap 3.20m 3.04m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack